It is projected that the animal model market share would generate around US$ 1,943.3 million in sales by 2024. Animals are easy to test in labs, have a shorter life cycle, and share a high level of genetic similarity.
The market as a whole is expected to expand at a moderate CAGR of 6% over the next ten years, according to the animal model demand study report. By the conclusion of this forecast period, the report projects that the global animal model industry will be valued close to US$ 3,476.8 million.
Get a Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3141
Key Takeaways from the Animal Model Market Study Report
- The animal model market in North America is expected to account for over 40% of the global market share in 2024, followed by Europe.
- The United States creates the most demand for preclinical animal models in North America and is poised to advance further with a 6.7% CAGR through 2034.
- Germany is expected to continue to be the most lucrative market for animal models in Europe, exhibiting a growth rate of 8.2% through 2034.
- The United Kingdom is another notable market for the use of laboratory animals, which is likely to exhibit a 6.6% CAGR till 2034.
- China is the leading supplier of animal models for preclinical research in Asia and is expected to witness a 6.1% CAGR through 2034.
“Rising demand for biomedical research animals and their increased use in the development of personalized medicine has created new opportunities for existing animal model suppliers. Further, more government support in the form of funding and subsidies for supplying laboratory animals in pharmacological studies has encouraged many start-ups in recent years,” – says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Competitive Landscape for the Animal Model Market Participants
The competition in the animal model industry is highly concentrated, and many contemporary participants are focused on the rat and mouse model segment. However, the approval and adoption of many other animal species, like pigs or non-human primates, is expected to diversify the market by increasing animal model suppliers.
Top Key Players Profiled in the Animal Model Market Report
- Charles River Laboratories International, Inc.
- Horizon Discovery Group plc.
- The Jackson Laboratory
- Taconic Biosciences, Inc.
- Genoway SA
- Eurofins Scientific SE
- Crown Bioscience, Inc.
- Envigo CRS SA
- Transposagen Biopharmaceuticals, Inc.
Recent Developments in the Animal Model Industry Players
In October 2021, Charles River Laboratories, located in Japan, was acquired by Jackson Laboratory to strengthen its position in Japan and grow its line of animal models. This acquisition is expected to enrich the company’s animal model solutions with humanized mice and sophisticated immunodeficient animals and help them advance their commercial development.
In May 2023, animal model researchers at University Hospital Carl Gustav Carus evolved a humanized rodent with a faulty gene. As per the reports, the gene results in congenital adrenal hyperplasia. This advancement can be a significant development for understanding the illness and finding new treatments for hyperplasia.
Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-3141
Key Segments Covered by Animal Model Industry Survey Report
By Species Type:
- Rats
- Mice
- Guinea Pigs
- Rabbits
- Monkeys
- Dogs
- Pigs
- Cats
- Other Species
By Application:
- Basic and Applied Research
- Drug Discovery and Development
- Other Applications
By End User:
- Academic & Research Institutions
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Other End Users
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia and Pacific
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
